James Hamilton
Fortune : 18 M $ au 31/05/2026
Fortune : 18 M $ au 31/05/2026
James C.
Hamilton is the founder of NanoValent Pharmaceuticals, Inc. Dr. Hamilton is Chief Medical Officer, Head-Research & Development at Arrowhead Pharmaceuticals, Inc. since 2025.
Formerly, Dr. Hamilton was Chief Executive Officer at Calando Pharmaceuticals, Inc. Dr. Hamilton completed undergraduate studies at Miami University and earned an MBA and a doctorate from The Ohio State University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 05/03/2026 | 236 958 ( 0,17 % ) | 18 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/02/2025 |
| Sociétés | Poste | Fin |
|---|---|---|
NanoValent Pharmaceuticals, Inc.
NanoValent Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and manufactures proprietary targeted nanoparticle drugs | Fondateur | - |
Calando Pharmaceuticals, Inc.
Calando Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in the design and development of drug-delivery-enhanced small molecule therapeutics | President | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Arrowhead Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drugs to treat intractable diseases | Health Technology |
Calando Pharmaceuticals, Inc.
Calando Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in the design and development of drug-delivery-enhanced small molecule therapeutics | Health Technology |
Miami University
Miami University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Ohio State University
The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NanoValent Pharmaceuticals, Inc.
NanoValent Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and manufactures proprietary targeted nanoparticle drugs | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national